Cellens Raises $6.5M to Advance Its AI-Driven Mechanobiology Platform for Non-Invasive Bladder Cancer Diagnostics
BOSTON, MA, UNITED STATES, December 23, 2025 /EINPresswire.com/ — Cellens, Inc., a cancer diagnostics company pioneering a new mechanobiology and AI-driven platform, BioFeel™, for non-invasive cancer detection, has raised a $6.5M Series Seed round. The financing follows compelling early clinical data generated with leading urologists at Harvard’s Brigham and Women’s Hospital, showing that the company’s […]
